Healthcare & Life Sciences
Achillion Pharmaceuticals
United States
About
Achillion Pharmaceuticals is a pharmaceutical company developing treatments for patients with challenging infectious diseases, including hepatitis C and resistant bacterial infections. The company went public in 2006.
Explore Achillion Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.